Circulating acute phase cytokines and cytokine inhibitors in fulminant hepatic failure: associations with mortality and haemodynamics

References

• Wend on JA, Harrison PM, Keays R, Gimson AE, Alexander GJ, Williams R. Effects of vasopressor agents and epopro-stenol on systemic hemodynamics and oxygen transport in fulminant hepatic failure. Hepatology 1992;15:1067–1071.
   PubMed Web of Science ®Google Scholar
• Kiener PA, Marek F, Rodgers G, Lin PF, Warr G, DesiderioJ. Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A. J.Immunol. 1988;141: 870–874.
   PubMed Web of Science ®Google Scholar
• Rolando N, Harvey F, Brahm J, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J. Hepatol. 1991;12:1–9.
   PubMed Web of Science ®Google Scholar
• Rolando N, Harvey F, Brahm J, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990;11: 49–53.
   PubMed Web of Science ®Google Scholar
• Muto Y, Noun Aria KT, Meager A, Alexander GJ, Eddleston AL, Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 19882: 72–74.
   Google Scholar
• de la Mata M, Meager A, Rolando N, et al. Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. Clin. Exp. Immunol. 1990; 82: 479–484.
   PubMed Web of Science ®Google Scholar
• Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann.Intern.Med. 1990; 112: 917–920.
   Google Scholar
• Sheron N, Bird G, Goka J, Alexander G, Williams R. Elevated plasma interleuldn-6 and increased severity and mortality in alcoholic hepatitis. Clin.Exp.Immunol. 1991; 84: 449–453.
   Google Scholar
• Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytoldnes in chronic liver diseases. Gastroenterology 1992; 103: 264–274.
   PubMed Web of Science ®Google Scholar
• Trey C, Davidson CS. Popper H, Schaffner E, (Eds). The management of fulminant hepatic failure. In: Progress in Liver Disease. 3rd edn. New York: Grune and Stratton; 1986; p. 282–298.
   Google Scholar
• Beutler B, Cerami A. Cachectin, cachexia, and shock. Ann. Rev. Med. 1988; 39: 75–83.
   PubMed Web of Science ®Google Scholar
• Endo S, Inada K, Inoue Y, et al. Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ. Shock 1992; 38: 264–274.
   PubMedGoogle Scholar
• Bellomo R. The cytoldne network in the critically ill. Anaesth. Intensive Care 1992; 20: 288–302.
   PubMed Web of Science ®Google Scholar
• Marty C, Misset B, Tamion F, Fitting C, Cadet J, Cavaillon JM. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit.Care Med. 1994; 22: 673–679.
   PubMed Web of Science ®Google Scholar
• Engel A, Kern WV, Murdter G, Kern P. Kinetics and corre-lation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia. Infection 1994; 22: 160–164.
   PubMed Web of Science ®Google Scholar
• Hummel M, Czerlinski S, Friedel N, et al. Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist device patients before heart transplan-tation. Crit. Care Med. 1994; 22: 448–454.
   PubMed Web of Science ®Google Scholar
• Jacobson SH, Hylander B, Wretlind B, Brauner A. Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function. Nephron 1994; 67: 172–179.
   PubMed Web of Science ®Google Scholar
• Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene intercrine cytokine family. Ann. Rev. Immunol. 1991; 9: 617–648.
   PubMed Web of Science ®Google Scholar
• Hechtman DH, Cybulsky MI, Fuchs HJ, Baker JB, Gimbrone MAJ. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J. Immunol. 1991;147: 883–892.
   Google Scholar
• Solomkin JS, Bass RC, Bjornson HS, Tindal CJ, Babcock GF. Alterations of neutrophil responses to tumor necrosis factor alpha and interleukin-8 following human endotoxemia. Infect.Immun. 1994; 62: 943–947.
   Google Scholar
• Rolando N, Gimson A, Wade J, Philpott Howard J, Casewell M, Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993; 17: 196–201.
   Google Scholar
• Tilg H, Ceska M, Vogel W, Herold M, Margreiter R, Huber C. Interleukin-8 serum concentrations after liver transplantation. Transplantation 1992; 53: 800–803.
   PubMed Web of Science ®Google Scholar
• Le Moine 0, Marchant A, Goldman M, Dupont E, Deviere J. Cytokines in alcoholic liver cirrhosis. Acta Gastroenterol Belg. 1994; 57: 245–254.
   PubMed Web of Science ®Google Scholar
• Sheron N, Bird G, Koskinas J, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993; 18: 41–46.
   PubMed Web of Science ®Google Scholar
• Martich GD, Danner RL, Ceska M, Suffredini AF. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J.Exp.Med. 1991; 173: 1021–1024.
   PubMed Web of Science ®Google Scholar
• van Deventer SJ, Hart M, van der Poll T, Hack CE, Aarden LA. Endotoxin and tumor necrosis factor-alpha-induced interleukin-8 release in humans. J. Infect. Dis. 1993; 167: 461–454.
   Google Scholar
• Van Zee KJ, DeForge LE, Fischer E, et al. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J. Immu-nol. 1991; 146: 3478–3482.
   PubMed Web of Science ®Google Scholar
• Saijo S, Watanabe N, Kobayashi Y. Comparison of reactivity of monoclonal antibody (3F2) to trimeric tumor necrosis factor (TNF-alpha) with that to monomeric TNF-alpha. J. Biochem.Tokyo. 1995; 118: 28–32.
   Google Scholar
• Weinhold B, Bader A, Poli V, Ruther U. Interleuldn-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo. Biochem. J. 1997; 325: 617–621.
   PubMed Web of Science ®Google Scholar
• Banu N, Williams N. Immunochemical characterisation of megakaryocyte potentiator activity from mouse bone marrow. J. Cell Physiol. 1995; 163: 486–492.
   PubMed Web of Science ®Google Scholar
• Hack CE, De Groot ER, Felt Bersma RJ, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74: 1704-1710.
   Google Scholar
• Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann. Thorac. Surg. 1996; 61: 1714–1720.
   PubMed Web of Science ®Google Scholar
• Weber J, Gunn H, Yang J, et al. A phase I trial of intravenous interleuldn-6 in patients with advanced cancer. J. Immunother. Emphasis Tumor Immunol. 1994; 15: 292–302.
   PubMed Web of Science ®Google Scholar
• Woodroofe C, Muller W, Ruther U. Long-term consequences of interleukin-6 overexpression in transgenic mice. DNA Cell Biol. 1992; 11: 587–592.
   Google Scholar
• Libert C, Takahashi N, Cauwels A, Brouckaert P. Blueth-mann H, Fiers W. Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality. Eur.J.Immunol. 1994; 24: 2237–2242.
   Google Scholar
• Dalrymple SA, Slattery R, Aud DM, Krishna M, Lucian LA, Murray R. Interleuldn-6 is required for a protective immune response to systemic Escherichia coli infection. Infectimmun. 1996; 64: 3231–3235.
   PubMed Web of Science ®Google Scholar
• Cressman DE, Greenbaum LE, DeAngelis RA, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379–1383.
   PubMed Web of Science ®Google Scholar
• Fong YM, Marano MA, Moldawer LL, et al. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J. Clin. Invest. 1990; 85: 1896–1904.
   PubMed Web of Science ®Google Scholar
• Hammer GB, So SK, Al Uzri A, et al. Continuous venovenous hemofiltration with dialysis in combination with total hepatectomy and portocaval shunting. Bridge to liver transplantation. Transplantation 1996; 62: 130–132.
   Google Scholar
• Ringe B, Lubbe N, Kuse E, Frei U, Pichlmayr R. Total hepatectomy and liver transplantation as two-stage procedure. Ann. Surg. 1993; 218(1): 3–9.
   Google Scholar